glp 1 agonists canada Learning about Ozempic, a GLP-1 receptor agonist you've likely heard about! Please note and consider that there are risk factors and side effects with Ozempic and other drugs of this nature!💙🤍 #diabetes # Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists:

Semaglutide 2.4 mg weekly significantly reduced the primary endpoint (incidence of MACE)

Patients have reported decreased interest in alcohol and nicotine when taking GLP-1s, and observational studies have shown an association between treatment with GLP-1 medication and lower risk of alcohol and cannabis use disorders, opioid overdose, and alcohol-related hospitalization

Fineman MS, Shen LZ, Taylor K, Kim DD, Baron AD

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

Despite the pleiotropic benefits increasingly observed for existing novel AOMs, HCPs and patients should temper enthusiasm with potential long-term adverse effects, and costs to society and healthcare systems

Blood glucose lowering effect of DPP-4i DPP-4i are oral anti-diabetic drugs that function by blocking incretin degradation caused by DPP-4, as outlined earlier in this review